Our in vitro studies showed that silence of LINC01614 attenuated the progression of gastric cancer cells and enhanced the chemosensitivity of gastric cancer cells to cisplatin, suggesting that LINC01614 may serve as an oncogenic RNA in gastric cancer. The gene discussed is LINC01614; the disease is gastric cancer.